Scarab Genomics

Biotechnology Research • Madison, Wisconsin, United States • 11-20 Employees

Company overview

Headquarters	1202 Ann Street, Madison, WI 53713, US
Phone number	+18665115090
Website	scarabgenomics.com
SIC	873
Keywords	DNA, Sequencing, Protein, Clean Genome E. Coli, E. Coli, Crm197
Employees	11-20
Socials

Key Contacts at Scarab Genomics

Venkat Balakrishnan

Director Of Commercial Operations

Jaymie Sawyer

Member Board Of Directors

Frederick Blattner

Cofounder & Ceo

Scarab Genomics Email Formats

Scarab Genomics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@scarabgenomics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@scarabgenomics.com	100%

About Scarab Genomics

Scarab Genomics is advancing the future of bioproduction with engineered Clean Genome® E. coli strains. Founded on Dr. Fred Blattner’s groundbreaking E. coli genomics research at the University of Wisconsin–Madison, Scarab was established to commercialize Clean Genome technology—removing mobile DNA elements and unnecessary genes to create safer, more stable, and higher-performing cell factories. Our expanding library of Clean Genome strains delivers superior genetic stability, higher yields, and consistently cleaner products across proteins, peptides, nucleic acids, and scFvs. We also developed C-Flow™, a proprietary continuous fermentation system designed exclusively for Clean Genome strains, enabling steady-state production for weeks or even months, while dramatically accelerating process development and time to market. Whether for research, therapeutic production, or industrial applications, Scarab Genomics provides a more reliable foundation for bioproduction, helping innovators move from discovery to commercialization with greater confidence.

Scarab Genomics revenue & valuation

Annual revenue	$27,500,000
Revenue per employee	$1,964,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$88,000,000
Total funding	No funding